<DOC>
	<DOCNO>NCT00126100</DOCNO>
	<brief_summary>The purpose study determine whether stem cell mobilization granulocyte colony-stimulating factor ( G-CSF ) therapy patient acute myocardial infarction successful mechanical reperfusion reduces infarct size .</brief_summary>
	<brief_title>Bone Marrow Stem Cell Mobilisation Therapy Acute Myocardial Infarction ( AMI ) ( REVIVAL-2 )</brief_title>
	<detailed_description>Experimental study early-phase clinical trial suggest transplantation blood-derived bone marrow-derived progenitor cell may improve cardiac regeneration acute myocardial infarction . Granulocyte colony-stimulating factor ( G-CSF ) induce mobilization bone marrow stem cell , thereby , increase number circulate stem cell available cell myocardial regeneration .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Lenograstim</mesh_term>
	<criteria>STelevation acute myocardial infarction ( 5 day randomization ) Successful percutaneous coronary intervention [ PCI ] ( perform within 12 hour symptom onset ) Scintigraphic infarct size &gt; 5 % leave ventricle Written inform consent Age &lt; 18 year &gt; 80 year Congestive heart failure define Killip class &gt; 2 A history myocardial infarction Electrical hemodynamic instability Autoimmune diseases Fructose intolerance Malignancies Incompatibility filgrastim Known suspect pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2007</verification_date>
	<keyword>Stem Cells</keyword>
</DOC>